St. Jude Children's Research Hospital
Memphis, TN
Thirumala-Devi Kanneganti, PhD
St. Jude Children’s Research Hospital
Memphis, TN, United States
Dr. Thirumala-Devi Kanneganti is a Member and Vice Chair of the Immunology Department and Director of the Center of Excellence for Innate Immunity and Inflammation, and she holds the distinguished Rose Marie Thomas Endowed Chair, at St. Jude Children’s Research Hospital.
Dr. Kanneganti’s research has yielded fundamental insights into innate immunity, inflammation, and cell death. Notably, she identified the functions of key innate immune sensors and elucidated their upstream regulatory mechanisms and roles in diverse disease settings. Dr. Kanneganti has also pioneered the concept of the inflammatory cell death pathway PANoptosis, and her research has bridged major gaps in innate immunity, cell death, and inflammation. She continues to establish governing biological principles and define the physiological relevance of sensors and cell death pathways in infections, inflammatory diseases, and cancer. She has also identified regulatory mechanisms and functions for IL-1 family cytokines, and the synergism between TNF and IFN-?, which induces inflammatory cell death and “cytokine storm.” Consistently recognized for her exceptional contributions, Dr. Kanneganti has received numerous awards and has been named one of the worlds most highly cited researchers for seven consecutive years by Clarivate Analytics. She is a Fellow in the American Academy of Microbiology and the American Association for the Advancement of Science, and she recently received the 2024 American Association of Immunologists-Thermo Fisher Meritorious Career Award. By continually advancing basic and translational research, she remains at the forefront of her field.
Disclosures:
Molecular Mechanisms of Innate Immune Cell Death and Inflammation in Disease and Therapy
Sunday, September 29, 2024
8:32 AM – 8:47 AM ET